Lori Friedman – Biography

Last update: April 17, 2026

Executive profile

Lori was Senior Director, Translational Oncology at Sr. Director, Translational Oncology, and Director, Signal Transduction Research at Exelixis. Lori Friedman joined Oric Pharmaceuticals in 2023.

Lori Friedman is currently

Chief Scientific Officer at Oric Pharmaceuticals - View - Oric Pharmaceuticals org chart



Create your alert
to follow the career of Lori Friedman.

Education

Lori Friedman has a PhD in Molecular and Cell Biology from University of California, Berkeley and a Post-Doctoral in Breast Cancer Genetics from University of Cambridge.

They have also studied at University of California, Berkeley :

Find more alumni from University of California, Berkeley


They have also studied at University of Cambridge :

Find more alumni from University of Cambridge

The colleagues of Lori Friedman

Company Colleagues
Homonyms
  • Lori Friedman - Director of Human Resources - Belay
Industry Colleagues
  • In the Pharmaceuticals industry, Lori Friedman has 22,998 colleagues in 1,915 companies located in 68 countries. 10,754 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.

Report an error
Update the org chart details of Lori Friedman.

Get in Touch

Here are a few tips for establishing great contacts.

Through the switchboard, call Oric Pharmaceuticals at +1 650... and ask for Lori Friedman.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.